CXCL14 and NOS1 expression in specimens from patients with stage I–IIIA nonsmall cell lung cancer after curative resection
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference38 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016
2. Non-small-cell lung cancer;Goldstraw;Lancet,2011
3. Activating enhancer-binding protein-2 (nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection;Kim;Ann Thorac Surg,2011
4. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer;Mineo;J Clin Pathol,2004
5. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients;Pfannschmidt;Lung Cancer,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma;Therapeutic Advances in Medical Oncology;2023-01
2. The expanding roles of neuronal nitric oxide synthase (NOS1);PeerJ;2022-07-07
3. Construction and evaluation of a prognostic risk assessment model of gastric cancer by using hypoxia features;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2022-07
4. Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer;Frontiers in Oncology;2022-06-08
5. Integrated analysis of 14 lymphoma datasets revealed high expression of CXCL14 promotes cell migration in mantle cell lymphoma;Aging;2022-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3